Tuesday, May 21, 2024
- Advertisement -
More

    Latest Posts

    Seven’s Spotlight to take on Ozempic Revolution

    7NEWS Spotlight will investigate the worldwide shortage of Ozempic in a special TV event, featuring a studio audience and a panel of Australia’s top medical experts to explain everything about the Hollywood wonder drug.

    The Ozempic Revolution premieres Sunday 14 April at 8:45 pm on Channel Seven and 7plus

    Originally manufactured for people with Type 2 diabetes, Ozempic is now widely in demand as a remedy for weight loss.

    Australian PR expert Roxy Jacenko will be featured on the program and will open up about her Ozempic overdose. 

    “They [doctors] had never seen this before,” she tells the program. “My whole body was shaking. I couldn’t control my legs… it’s like I had no control of my body.”

    Host Michael User, who will be co-presenting alongside Sarah Greenhalgh, said Australia is on the verge of a health revolution and “the emotion in this topic is supercharged at the moment”.

    “People need Ozempic for diabetes and weight loss. They just want facts, information and help. Not judgement,” he said. “And that’s what we provide with our medical experts and panel members.

    “For some this is lifesaving. Some are desperate. Many are worried about supply. But there’s no doubt we’re about to see a radical shift in the treatment of obesity in Australia.”

    The new 7NEWS Spotlight program comes amidst the fallout of Bruce Lehrmann’s defamation case. Mark Llewellyn, executive producer of Spotlight, is reportedly leaving the network. He has been working as EP of the show since 2020.

    The Australian reports that Llewellyn has engaged employment lawyer, John Laxon, as he seeks to negotiate termination, and handed in his building security pass on Wednesday. The masthead also reports that network insiders have indicated that Llewellyn “might not be the only figure to depart Seven as the Spotlight scandal shakes out.”

    Speaking anonymously to The Sydney Morning Herald, a senior Seven executive described Llewellyn as “a dead man walking.”

    “He has appointed lawyers. The position is pretty untenable.”

    Seven has declined to comment.

    Llewellyn’s departure comes after ex-Spotlight producer Taylor Auerbach took to the stand in Lehrmann‘s case against Network 10 and Lisa Wilkinson last week. 

    In both a sworn affidavit and his testimony to the court, Auerbach detailed the lengths to which the program allegedly went to secure its now infamous interviews with Lehrmann – including reimbursement for illicit drugs and sex workers, $10,300 on Thai massages, several expensive dinners, and a $401.83 round of golf in Tasmania. This was on top of the company’s decision to pay for Lehrmann’s rent in Sydney, which had already been widely reported.

    At 10:15am on Monday 15 April, Federal Court Justice Michael Lee will deliver his judgment in the case.

    See also: Roundup: Lehrmann trial judgment date, TikTok launches new rewards app, Bluey

    The post Seven’s Spotlight to take on Ozempic Revolution appeared first on Mediaweek.

    Latest Posts

    - Advertisement -

    Don't Miss

    Stay in touch

    To be updated with all the latest news, offers and special announcements.